Your Health, We Care

Home > Photo Wall > Honor and qualification

Production approval for Larotretinib

Release date: 2024-07-10 14:07:34     Recommended: 100

05L0977_23 拉罗替尼 批文_00.jpg

Larotinib is the first specific targeting drug in the world that only targets a certain tumor regardless of tumor type. It can be used for 17 kinds of tumors, including breast cancer, colorectal cancer, lung cancer, thyroid, etc. Even if conventional therapy is ineffective, corresponding genes can be found through NTRK gene detection, which has a quick effect and a long acting time, and is suitable for adults and children.

Company News

Research News

Drug news